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ROTARY BLOOD PUMP
Ventricle assist devices are frequently used to boost blood circulation to assist
a heart which still functions but is not pumping sufficient blood for adequate
circulation. Rotary pumps are often the preferred type of pump for use as a ven-
tricle assist device because rotary pumps may be manufactured at a relatively low
cost and are typically less complex than other types of pumps. Rotary blood
pumps are increasingly used not only for ventricular assist applications, but
also for cardiopulmonarybypass procedures and percutaneous cardiopulmonarysup-
port applications in emergency cases. Clinical uses of rotary pumps are conven-
tionally limited to a few days due to shortcomings of these pumps, including
(I) blood damage which may occur when blood comes into contact with rotor bear-
ings, (2) problems of blood damage (hemolysis) and blood clotting (thrombosis)
caused by relative rotational movement of the components of the pump, (3) pump
and controller size and shape limitations necessary for implantation or con-
venient mobility, (4) weight limitations for implantation, (5) high power con-
sumption that requires a large power supply and causes excess heat flow from the
device of the body, and (6) complex sensors/electronics for rotary control.
The present invention is a rotary blood pump which includes a pump housing for
receiving a flow straightener, a rotor mounted on rotor bearings and having an
inducer portion and an impeller portion, and a diffuser. The entrance angle,
outlet angle, axial and radial clearances of blades associated with the flow
straightener, inducer portion, impeller portion and diffuser are optimized to
minimize hemolysis while maintaining pump efficiency. The rotor bearing includes
a bearing chamber that is filled with cross-linked blood or other biocompatible
material. A back emf integrated circuit regulates rotor operation and a micro-
computer may be used to control one or more back emf integrated circuits. A
plurality of magnets are disposed in each of a plurality of impeller blades with
a small air gap. A stator may be axially adjusted on the pump housing to absorb
bearing load a maximize pump efficiency.
Novelty is believed to reside in a number of features of this optimally
engineered device, including two-stage pump having unique blade shape and orien-
tation, configuration to reduced power requirements, as well as blood damage from
high speed operation, and a novel application of back emf motor control for high
pump efficiency.
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Field of the Invention
The invention described herein was made in the performance of work under
a NASA contract and is subject to the provisions of Section 305 of the National
Aeronautics and Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 U.S.C.
2457).
Technical Field
The present invention relates generally to rotary blood pumps. More
specifically, the present invention relates to an axial flow ventricle assist blood pump.
10 Back_m'ound of the Invention
Ventricle assist devices are frequently used to boost blood circulation to assist
a heart which still functions but is not pumping sufficient blood for adequate
circulation. Rotary pumps are often the preferred type of pump for use as a ventricle
assist device compared to other types of pumps which may use pistons, rollers,
15 diaphragms, or compliance chambers. This is partially because rotary pumps may be
manufactured at a relatively low cost and are typically less complex than other types
of pumps. Other types of blood pumps may cost up to $50,000 per unit and, due to
financial limitations, are therefore not available for use upon the large population
which could benefit from such pumps. Rotary blood pumps are increasingly used not
20 only for ventricular assist applications, but also for cardiopulmonary bypass procedures
and percutaneous cardiopulmonary support applications in emergency cases.
Clinical uses of rotary pumps are conventionally limited to a few days due to
shortcomings of these pumps. A non-comprehensive list of such problems or
shortcomings would include the following: (1) blood damage which may occur when
25 blood comes into contact with rotor bearings, (2) the need for bearing purge systems
which may require percutaneous (through the skin) saline solution pump systems, (3)
bearing seizure resulting from the considerable thrust and torque loads, or from dried
blood sticking on the bearing surfaces, (4) problems of blood damage (hemolysis) and
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blood clotting (thrombosis) caused by relative rotational movement of the components
of the pump, (5) pump and control size and shape limitations necessary for
implantation or convenient mobility, (6) weight limitations for implantation to avoid
tearing of implant grafts due to inertia of sudden movement, (7) difficulty in
5 coordinating and optimizing the many pump design parameters which may affect
hemolysis, (8) high power consumption that requires a larger power supply, (9) motor
inefficiency caused by a large air gap between motor windings and drive magnets, (10)
heat flow from the device to the body, (11) complex Hall Effect sensors/electronics
for rotary control, (12) the substantial desire for minimizing percutaneous (through the
10 skin) insertions, including support lines and tubes, and (13) large pump and related
hose internal volume which may cause an initial shock when filled with saline solution
while starting the pump.
Although a significant amount of effort has been applied to solving the
problems associated with rotary pumps, there is still a great demand for a safe,
15 reliable, and durable blood pump that may be used for longer term applications. The
estimated need for a simple and long term ventricle assist device (VAD) is presently
projected at between 50,000 and 100,000 patients per year in the United States alone.
The following patents describe attempts made to solve problems associated
with rotary blood pumps, including ventricle assist devices.
20 U.S. Patent No. 4,625,712 to R.K. Wampler discloses a full-flow cardiac assist
device for cariogenic shock patients which may be inserted into the heart through the
femoral artery and driven via a flexible cable from an external power source. A
catheter attached to the pump supplies the pump bearings with a blood-compatible
purge fluid to prevent thrombus formation and the introduction of blood elements
25 between rotating and stationary elements. Due to the very small diameter of the
pump, rotational speeds on the order of 10,000 to 20,000 rpm are used to produce a
blood flow of about four liters per minute.
U.S. Patent No. 4,957,504 to W. M. Chardack discloses an implantable blood
pump for providing either continuous or pulsatile blood flow to the heart. The pump
30 includes a stator having a cylindrical opening, an annular array of electromagnets
disposed in a circle about the stator concentric with the cylindrical opening, a bearing
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carried by the stator and extending across the cylindrical opening, and a rotor
supported by the bearing. The rotor is in the form of an Archimedes screw and has
a permanent magnet in its periphery which lies in the same plane as the circular array
of electromagnets for being driven in stepper motor fashion.
5 U.S. Patent No. 4,944,722 to J.W. Carriker discloses a percutaneously
insertable intravascular axial flow blood pump with a rotor extension and drive cable
fitting designed so that the thrust bearing surfaces of the purge seal and cable fitting
can be preloaded.
U.S. Patent No. 4,817,586 to R_K. Wampler discloses an intravascular flow
10 blood pump having blood exit apertures in the cylindrical outside wall of the pump
housing between the rotor blades and the rotor journal bearing.
U.S. Patent No. 4,908,012 to Moise et al. discloses an implantable ventricular
assist system having a high-speed axial flow blood pump. The pump includes a blood
tube in which the pump rotor and stator are coaxially contained, and a motor stator
15 surrounding the blood duct. A permanent mag_et motor rotor is integral with the
pump rotor. Purge fluid for the hydrodynamic bearings of the device and power for
the motor are preferably percutaneously introduced from extra-corporeal sources worn
by the patient.
U.S. Patent No. 4,779,614 to J.C. Moise discloses an implantable axial flow
20 blood pump which includes a magnetically suspended rotor of a relative small
diameter disposed without bearings in a cylindrical blood conduit. Neodymium-boron-
iron rotor magnets allow a substantial gap between the static motor armature and the
rotor. Magnetically permeable strips in opposite ends of the pump stator blades
transmit to Hall sensors the variations in an annular magnetic field surrounding the
25 rotor and adjacent the ends of the pump stator blades.
U.S. Patent No. 5,049,134 to Golding et al. discloses a seal free centrifugal
impeller supported in a pump housing by fluid bearings through which a blood flow
passageway is provided.
U.S. Patent No. 4,382,199 to M.S. Isacson discloses a hydrodynamic bearing
30 system for use with a left ventricle assist device. The bearings are formed by the fluid
in the gap between the rotor and the stator.
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U.S. Patent No. 4,135,253 to Reich et al. discloses a centrifugal blood pump
provided with a magnetic drive system which permits a synchronous magnetic
coupling with a separate power unit disposed immediately adjacent the pump housing
but outside of the skin surface. The pump has a single moving part which includes
the combination of an impeller connected to a magnetic drive rotor. The magnetic
drive system floats on a fluid surface of saline solution.
U.S. Patent No. 4,507,048 to J. Belenger discloses a centrifugal blood pump
with a bell-shaped housing having a suction inlet at the apex and a tangential outlet
adjacent the base. A conical rotator is d_:iven by spaced permanent magnets embedded
in the base of the rotator and an externally generated rotating magnetic field.
U.S. Patent No. 4,688,998 to Olsen et al. discloses a pump with a magnetically
suspended and magnetically rotated impeller. The impeller may be configured for
axial flow with a hollow, cylindrical-type impeller with impeller vanes on the internal
surface thereof. The impeller includes a plurality of internally embedded, permanent
magnets that cooperate with electromagnets for drive and position control of the
impeller.
U.S. Patent No. 4,763,032 to Bramm et al. discloses a magnetic rotor bearing
for suspending a rotor for an axial or radial-centrifugal blood pump in a contact-free
manner, and comprising a permanent and electromagnetic arrangement.
U.S. Patent No. 4,846,152 to Wampler et al. discloses a miniature high-speed
intravascular blood pump with two rows of rotor blades and a single row of stator
blades within a tubular housing. The f'u'st row of blades has no provision for a
variable pitch, but produces a mixed centrifugal and axial flow by increasing hub
diameter. The second row of blades is axially spaced from the f'trst row, and produces
a purely axial flow. The stator blades are reverse twisted to straighten and slow the
blood flow.
U.S. Patent No. 4,944,748 to Bramm et al. discloses an impeller in a blood
pump supported by permanent magnets on the impeller and pump housing, which are
stabilized by an electromagnet on the pump housing. The impeller is rotated
magnetically, and stator coils in the housing are supplied with electric currents having
a frequency and amplitude adjusted in relation to blood pressure at the pump inlet.
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U.S. Patent No. 4,994,078 to R.K. Jarvik discloses an electrically powered
rotary hydrodynamic pump having motor windings and laminations disposed radially
about an annular blood channel, and having a motor rotor disposed therein such that
an annular blood channel passes through the gap between the motor rotor and the
windings.
U.S. Patent No. 5,055,005 to Kletschka discloses a fluid pump with an
electromagnetically driven rotary impeller levitated by localized opposed fluid forces.
In spite of the effort evidenced by the above patents, there remains the need
for an improved rotary pump for use as a ventricle assist device that is reliable,
compact, requires limited percutaneous insertions, and produces fewer blood damage
problems. Those skilled in the art will appreciate the features of the present invention
which addresses these and other problems.
Statement of the Invention
The present invention provides a rotary blood pump which includes a pump
15 housing defining a blood flow path therethrough. A first stator having a fin'st stator
field winding is used to produce a first stator magnetic field. A flu'st rotor is mounted
within the pump housing for rotation in response to the first stator magnetic field. The
first rotor carries a blade thereon to propel blood through the pump housing along the
blood flow path. At least one magnet is secured to the fin'st rotor and produces a first
20 rotor magnetic field that passes through the first stator field winding during rotation
of the first rotor to thereby induce a back emf within the first stator field winding.
Back emf sensor circuitry connected to the fin'st stator field winding senses back emf
produced during the rotation of the fin'st rotor within the pump housing. In one
embodiment of the present invention, at least one magnet is implanted in each of a
25 plurality of impeller blades to produce rotational movement of the rotor.
The rotary pump also includes, in a preferred embodiment, an inducer portion
of the rotor having a plurality of inducer blades equidistantly disposed about a
circumference of the rotor with each inducer blade having a variable pitch along its
axial length. An interconnection blade portion connects at least one of the inducer
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blades to at least one impeller blade to form a continuous blade extending through said
inducer and impeller portions of the rotor.
The rotary pump preferably includes
supporting the rotor within the pump housing.
a f'trst rotor bearing for rotatably
The rotor bearing includes a curved
5 bearing surface fixed with respect to the pump housing. The fixed bearing surface
receives a rotating member having a rotating curved bearing surface. The fixed
bearing surface and the rotating curved bearing surface define a bearing chamber
which is filled with bio-compatible material.
An object of the present invention is to provide an improved rotary blood
10 pump.
A further object is to provide an improved control circuit for controlling a rotor
within the pump in response to a back emf produced in stator windings.
Another object is to provide an improved rotor bearing for which cross-linked
blood forms a bearing surface and blood seal.
15 Yet another object of the present invention is to provide a method for
optimizing pump parameters to reduce blood hemolysis.
A feature of the present invention is a reduced air gap between permanent
magnets on the rotor and the stator winding.
Another feature of the present invention is an impeller having a variable pitch
20 blade.
Another feature of the present invention is a back emf integrated circuit for
controlling rotor operation.
An advantage of the present invention is improved rotor control.
Another advantage of the present invention is quantifiably reduced damage to
25 blood.
30
Yet another advantage of the present invention is an elimination of the need
for a bearing purge system requiring saline carrying tubes penetrating through the skin.
Other objects, features and intended advantages of the present invention will
be readily apparent by the references to the following detailed description in
connection with the accompanying drawings and claims.
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Brief Description of the Drawings
Fig. 1 is an elevational view, partially in section, of a rotary blood pump in
accord with the present invention;
Fig. 2 is an end view of a stator showing stator laminations stacked to form
5 a skewed stator;
Fig. 2A is an elevational view indicating the skewed path of stator field
windings through the stator;
Fig. 3 is an elevational view, partially in section, of an alternative embodiment
rotary blood pump having distinct impeller and inducer blades;
10 Fig. 4 is a cross-sectional view of a portion of an impeller showing non-
radiused blade tips;
Fig. 5 is a block diagram of a control sy stem including a back emf integrated
circuit and a microprocessor;
Fig. 6A is an elevational view, partially in section, of a ball-socket rotor
15 bearing having a bearing chamber filled with bio-compatible material;
Fig. 6B is an elevational view, partially in section, of a shaft journal rotor
bearing having a bearing chamber filled with bio-compatible material;
Fig. 6C is an elevational view, partially in section, having a rotor bearing
washed from increased blood flow caused by a bend in the pump housing;
20 Fig. 6D is an elevational view, partially in section, showing a rotor bearing
shaft having blood flow passages along the shaft periphery;
Fig. 6E is a cross-sectional view along line 6E-6E;
Fig. 6F is an elevational view, partially in section, of a rotor bearing for
supporting the rotor in cantilevered fashion;
25 Fig. 7 is a chart showing optimum pump parameter components determined
from methods of optimizing pump parameters to minimize hemolysis;
Fig. 8 shows the test matrix of the present invention for optimizing pump
parameters to minimize hemolysis while maximizing pump efficiency;
Fig. 9 is a graph showing change in inducer blade pitch along the axial length
30 of the inducer; and
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Fig. 10 is an elevational view, partially in section, of two axially spaced pumps
for separate or combined operation in accord with the present invention.
While the invention will be described in connection with the presently
preferred embodiments, it will be understood that it is not intended to limit the
invention to these embodiments. On the contrary, it is intended to cover all
alternatives, modifications, and equivalents as may be included in the spirit of the
invention.
Brief Description of Preferred Embodiments
The present invention describes a rotary blood pump which has an improved
10 rotor control system. The rotary pump has a pump blade geometry optimized by a
method of the present invention to provide high pump efficiency while minimizing
hemolysis and thrombus (hemolysis is defined quantitatively hereinafter). The pump
requires less than 10 watts of power to pump 5 liters/minute against a pressure head
of 100 mm Hg. A preferred embodiment of the pump weighs 53 grams, has a length
15 of 75 mm, and a diameter of 25 mm. An index of hemolysis of 0.018 g/100 liters
pumped has been achieved, although using the method of this invention, further
reductions are possible. For reference, a more standard roller pump has an index of
hemolysis of 0.06 g/100 liters. Published articles concerning aspects of the present
invention are hereby incorporated by reference and include the following: (1) "In Vitro
20 Performance of the B ayl0r/NASA Axial Flow Pump", Artificial Organs, 1993 Volume
17, number 7, page 609-613; (2) "Development of Baylor/NASA Axial Flow VAD,
Artificial Organs, 1993, Volume 17, page 469.
Referring now to the drawings, and more particularly to Fig. 1, there is a
shown a rotary blood pump 10 in accord with the present invention. Blood pump 10
25 includes a preferably metallic tubular pump housing 12 which is, in a preferred
embodiment, a straight-sided cylinder. Pump housing 12 has a smooth inner bore wall
15 to minimize thrombus formation. Pump housing 12 defines a blood flow path 13
therethrough in the direction indicated by blood flow arrows shown in Fig. i.
Front and rear clamps 14 and 16, respectively, are used to secure flow
30 straightener 18 and diffuser 20 within pump housing 12. Pump housing 12 is
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sufficiently thin-wailed so that the tightening of clamps 14 and 16 with clamp screws
22 locally deforms pump housing 12 about flow straightener 18 and diffuser 20 to
affix these components in position. The clamps provide a very convenient means of
securing the rotor assembly. Alternatively, other means for securing these components
5 could be used, such as spot welding, fasteners, and interference fit.
Flow straightener 18 serves two basic functions: (1) it straightens blood flow
to reduce hemolysis while improving pump efficiency, and (2) it provides a support
structure for front ball-socket bearing assembly 24, as discussed hereinafter. By
straightening the flow of blood as it ini_aily flows into the entrance 36 of pump 10,
10 hydraulic efficiency is increased. Straightening the blood flow also reduces turbulence
to increase the pump pressure. Fig. 7 lists optimal values and permissible pump
parameter ranges for the flow straightener 18 and the other pump components.
Flow straightener 18 preferably has four fixed blades 26, but could have only
two blades. Too many blades impede blood flow, while too few blades reduces pump
15 efficiency. For purposes of loweringthrombosis, the front edge 28 of each blade 26
is sloped from inner housing wail 15 to flow straightener hub 32 so that blood trauma
by contact with blades 26 is minimized. Also to reduce blood trauma, flow
straightener hub 32 is cylindrical with a round leading surface 34. Surface 34 may
also be hyperbolical or generally bullet-shaped for this purpose. An alternative
20 embodiment flow straightener 18a is shown in Fig. 3, and does not have the sloping
front edge blades.
The preferred angle of attack of blades 26 is 90 ° , i.e., the blades would
intersect a plane transverse to cylindrical housing 12 at an angle of 90 °. This
reference for the angle of attack or pitch of the blades will be used throughout this
25 specification.
Flow straightener 18 is preferably metallic, but may also be formed of plastic.
If formed of plastic and secured in place by clamp 14, it is necessary to reinforce flow
straightener 18 with, for instance, metallic supports to prevent plastic creep
deformation. The plastic creep deformation phenomena might otherwise eventually
30 cause flow straightener 18 to come loose from clamp 14. Reinforcement is also
necessary with respect to other clamped plastic pump components.
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Diffuser 20 also has two basic purposes: (1) it de-accelerates and redirects the
outflow at blood flow path exit 40 axially to boost pump performance, and (2) it
serves as a support structure for the rear rotor bearing 42. Diffuser 20 preferably has
from 5 to 8 fixed blades 38, with 6 blades being presently preferred. Blades 38 are
5 fixably engaged with pump housing 12 after rear clamp 16 is tightened by screw 22.
To perform the function of de-acceleration and axial redirection of blood flow,
each diffuser blade 38 has an entrance angle of from about I0 ° to 25 ° for slowing the
blood down, and an outlet angle of from about 80 ° to 90 ° for redirecting blood flow
in an axial direction. Presently prefei'red blade geometry is listed in Fig. 7 and
10 includes an entrance angle of 15 ° and an outlet angle of 90 ° . Tail cone 44 of diffuser
20 is hyperbolical or generally bullet-shaped to reduce turbulence or wake of blood
flow from pump 10 so as to minimize blood damage from such turbulence. Somewhat
surprisingly, it was found that increasing the number of fixed blades tends to decrease
hemolysis.
15 Rotor 46 is supported for rotary movement with pump housing 12 by front and
rear bearings 24 and 42, respectively. Rotor 46 is divided into two portions along its
axis based on the type and function of the blades disposed thereon. Inducer portion
48 is disposed in the front part of rotor 46, i.e., nearer to the pump inlet 36. Impeller
portion 50 is disposed in the rear part of rotor 46 closer to pump outlet 40. It has
20 been found that including an inducer portion in an axial flow pump, along with an
impeller portion, significantly reduces hemolysis.
Fig. 3 shows an alternative embodiment pump of the present invention which
provides for two distinct sets of axially spaced blades which more clearly distinguish
the inducer portion of the rotor from the impeller portion of the rotor. Corresponding
25 components of pump 10 and 10a are given the same number, with the difference of
an "a" suffix to distinguish the components for comparison purposes as necessary. A
reference to one number is therefore a reference to its corresponding number in this
specification, unless otherwise stated. Where components are substantially different
between the two pump versions, completely new numbers are assigned. In pump 10a,
30 inducer portion 48a is separated from impeller portion 50a of rotor 46a by gap 49a,
which is preferably less than 0.10 inches. Inducer blade 52a may be tapered (not
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shown) at forward end 56a so that blade 52a has a smaller radial length at forward end
56a, perhaps even blending into hub 73. However, using the method of the present
invention, it has been found that a continuous blade pump has even more reduced
levels of hemolysis than the non-continuous blade pump 10a. Thus, pump 10 shown
5 in Fig. 1 is the presently preferred embodiment.
Inducer blades 52 on inducer 53 have a variable pitch along their axial length.
Fig. 9 shows an inducer blade angle profile that plots angle of attack in degrees versus
axial position on inducer 53 in inches. It was found that the inducer portion 48
reduced hemolysis by approximately 45% from a pump design without the inducer.
10 Hydraulic efficiency was also increased as the rotation speed required to pump 5
liters/min of blood at 100 mm Hg. dropped from 12,600 rpm to 10,800 rpm. The
inducer blades 52 pre-rotate the blood before it enters the main pumping or impeller
54 to reduce hemolysis.
Inducer blades 52 also achieve a pumping action that effectively produces a
15 two-stage, increased efficiency pump. Optimum inducer blade geometry for minimal
hemolysis and maximum pump efficiency is listed for specific parts of inducer blade
52 in the chart of Fig. 7. Thus, the entrance angle of leading end 56 of inducer blade
52 is preferably 10 °, but has a preferred range from about 10 ° to 20 °. The shallow
entrance angle effectively engages the blood for movement without damaging the
20 blood. The pitch of inducer blade 52 continues to change along its axial length, and
preferably is about 30 ° at midpoint 58 of the blade. The tailing end 60 of inducer
blade 52 preferably has an outlet angle of 20 ° . This variable pitch is described in
Fig. 9, which shows how pitch varies with the axial length of inducer 53. As well,
it is desired that inducer blades have a wrap of preferably 240 ° around rotor 46. The
25 presently preferred overlap of each blade over other blades is 120 ° or a 50% overlap.
The chart of Fig. 7 provides a complete listing of relevant pump parameter values,
including preferred ranges of operation. Outside of these ranges, pump efficiency
drops and/or blood damage is more likely to occur.
Pump 10 includes an interconnecting blade portion 62 which is not included
30 in pump 10a. Although the two-stage pump 10a produces significantly reduced
hemolysis and efficient pump operation compared to a single stage pump, it has been
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discovered that by interconnecting inducer blades 52 with impeller blades 54 with
interconnecting blade portion 62, hemolysis may be reduced to even lower levels while
maintaining efficient pump operation.
Impeller blades 54 on impeller 55 have an entrance angle in leading end region
5 64 of preferably 20". This may be seen more clearly in Fig. 3, which has no
interconnecting blade portion 62. The entrance angle preferably smoothly tapers to
an optimum preferred outlet angle of 90" at blade tailing end region 66. The optimum
ranges of operation for the entrance and outlet angles is given in Fig. 7.
Impeller blades 54 include axially longer impeller blades, such as longer blade
10 68, and axially shorter impeller blades, such as shorter blade 70. The alternate long
and short blade arrangement on impeller 55 accommodates multiple magnetic poles
for electric motor operation as discussed hereinafter, and still maintains adequate flow
area through impeller 55. Presently, the preferred number of impeller blades is six,
but a range from two to six blades provides permissible pump efficiency. If impeller
15 55 included six axially longer blades, such as longer blade 68, the flow area through
impeller portion 50 is restricted to such an extent that the blades actually begin to
block the flow they are intended to produce.
Using the method of this invention, it was unexpectedly discovered that
hemolysis does not necessarily increase with the number of blades, as anticipated.
20 The alternating long-short blade arrangement of the six bladed impeller of the present
invention does not cause hemolysis any more significantly than a two-bladed impeller.
In some cases, an impeller with four long blades may cause more hemolysis than
either a two or six bladed impeller. It is possible that the degree of hemolysis
depends more on the number of long blades rather than the total number of blades.
25 Fig. 4 shows a portion of impeller 55 in cross-section to illustrate the
substantially fiat, non-radiused blade tips 72. It has been unexpectedly found, using
the method of this invention, that flat or substantially fiat, non-radiused blade tips have
substantially the same pump response, but do not produce significantly different
hemolysis results from rounded or radiused blade tips. It was anticipated that flat
30 blade tips would produce higher hemolysis. Because fiat blade tips are less expensive
to manufacture in conjunction with magnets to be used in the blades as discussed
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hereinafter, flat blade tips comprise the presently preferred embodiment. Further test
results are discussed in greater detail in the previously noted articles incorporated
herein by reference.
Fig. 4 also illustrates a preferred rotor hub 73 with outside diameter 74
5 compared to the overall outside diameter 76 of inducer 53 and/or impeller 55. The
preferred ratio is 0.48, although a range of 0.45 to 0.55 permits excellent pump
operation. If the hub is smaller than permitted by this range, blood becomes
excessively swirled and may tend to recirculate within pump 10 in the wrong flow
direction to possibly damage the blood as well as reduce pump efficiency. If the hub
10 is too large so as to be outside of this range, the hub tends to block flow through the
pump 10.
The radial clearance 78 between inducer 53 and/or impeller 55 with respect to
the pump housing inner wall 15 is preferably in the range of about 0.003 inches to
0.015 inches. Using a test matrix as per the method of this invention, it was
15 unexpectedly discovered that smaller radial clearances lowered hemolysis. It was
expected that smaller clearances would produce greater blood damage due to higher
sheer stresses on the blood. The presently preferred radial clearance 78 is about 0.005
inches. Axial clearances between components, such as flow straightener 18, rotor 46,
and diffuser 201 are shown in Fig. 7. Axial clearances should be within the ranges
20 shown to improve pump efficiency and to reduce hemolysis.
In order to reduce the air gap between stator 80 and magnets 82, the magnets
are preferably sealingly mounted within impeller blades 54. Reducing the air gap
between the stator 86 and the magnets 82 increases motor efficiency, because magnetic
flux is not as diffused as in motor designs with large air gaps. The preferred radial
25 spacing or air gap between magnets 82 and stator 80 is from 0.01 inches to 0.025
inches. Magnets 82 are preferably rare earth magnets because of the higher magnetic
flux produced by such magnets. Each magnet 82 is encapsulated in an individual
pocket 84 to eliminate corrosion. Because magnets are individualized, motor torque
and rotor weight can be easily adjusted in the manufacturing stage to provide motors
30 that are tailored to the type of pump performance necessary without producing
excessive pump weight.
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Field winding 88 generates a magnetic field to rotate rotor 46. Stator 80 is
comprised of individual stator laminations 86 to eliminate eddy currents that generate
heat and reduce efficiency. Heat flow from pump 10 is directed both into the blood
stream and into the tissues surrounding pump 10. In this way, the blood is not heated
5 in a manner that may damage the blood and, as well, the surrounding tissues do not
have to absorb all the heat. Heat conductive flow paths using thermally conductive
material, such as the metal of the stator or a thermally conductive gel, may be used
to provide approximately the desired ratio of heat flow to the tissues compared to the
heat flow to the blood.
10 As illustrated in Fig. 2, stator 80, comprised of individual laminations 86, is
stacked in a presently preferred skewed manner such that pathways 90 provide a motor
winding pathway that is offset from the rotor axis 92. The skew of laminations 86
may or may not correspond in some manner with the offset angle or changing offset
angle of the row of magnets 82, and is not limited to the position shown in Fig. 2.
15 A skewed stator 80 is also indicated in Fig. 2A, which shows an offset path from axis
92 for the field windings 88 which travel through stator 80. The skewing angle or
offset from the rotor axis is used to optimize performance. The skewing angle of
stator 80 may be variable rather than fixed along its length. While skewed stator 80
is the presently preferred embodiment, other factors or combinations of factors (e.g.
20 small air gap, magnet orientation, etc.) produce excellent pump and motor performance
without a skewed stator.
An axial force is produced on rotor 46 during rotation, which can be varied by
moving stator 80 axially along pump housing 12. Stator 80 is axially adjustable for
this purpose, and could be fixed in position during manufacturing for optimal
25 performance given the number of magnets to be used and given other factors discussed
hereinafter. The axial force thus produced can be used to offset the thrust created
during pumping to reduce the load on the front or rear bearing assemblies 24 and 42,
respectively. The axial positioning of stator 80 may also be used to optimize electrical
motor efficiency.
30 Referring to Fig. 5, a block diagram of the control system 100 of the present
invention is shown. Note that control system 100 may operate two motors 1 and 2,
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such as shown in Fig. 10. For some applications, either for implantation or for
external use, it may be desirable to have two pumps connected either in parallel or in
series. Thus, control system 100 can be easily configured for this purpose if desired.
In addition, magnets (not shown) may be placed in the inducer hub to provide a
5 secondary motor in the case of primary motor or controller failure. Various other
back-up and redundancy configurations may be used.
For instance, in an axially spaced pump configuration shown in Fig. 10, motors
1 and 2 are axially displaced from each other and may be operated separately or in
conjunction with each other as control system 100 regulates power, as discussed
10 hereinafter, to axially spaced stators 207 and 208 containing stator windings 210 and
212, respectively. Ball-socket bearing 203 on modified diffuser 204 rotatably supports
rotor 205 of motor 2, which is axially spaced from rotor 206 of motor 1. Diffuser 204
acts as a flow straightener when independent operation of motor 2 is desired. Control
system 100 may be used to operate both motors simultaneously or to turn one motor
15 on if micro-controller 102 senses that another motor has failed. Micro-controller 102
may be programmed for pulsatile motor operation or continuous speed motor operation
of one or more motors, as desired.
If only one pump is to be used, extra components may be removed. In Fig. 5,
except for micro-controller 102, most components are duplicated to allow for operation
20 of the two motors. For convenience, reference to corresponding components will be
made to one number, with the corresponding component having an "a" suffix. Control
system 100 operates either manually or by micro-control as discussed subsequently,
and may be used for test purposes if desired.
Control system 100 applies current to stator windings 88. Preferably stator 80
25 includes three stator windings 88. Stator 80 generates a routing magnetic field which
magnets 82 and thus rotor 46 follow to produce motion. The motor stator may be
three phase "Y" or "Delta" wound. The operation of the brushless D.C. motor of the
present invention requires a proper sequence of power to be applied to stator windings
88. Two stator windings 88 have power applied to them at any one time. By
30 sequencing the voltage on and off to the respective stator windings 88, a routing
magnetic field is produced.
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A preferred embodiment three-phase motor requires a repetitive sequence of
six states to generate a rotating magnetic field, although other commutation schemes
could be used. The six states are produced by electronic commutation provided by
power F.E.T.'s 104. If Motor 1 were sequenced through the six electrical states at a
5 controlled frequency without feedback, its operation would be that of a stepper motor.
In such a mode of operation, the motor rapidly loses its ability to generate torque as
the rpm's increase.
Control system 100 detects back electromotive force or back emf to control
motor operation. Whenever a conductor, such as field winding 88, is cut by moving
10 magnetic lines of force, such as are generated by magnets 82, a voltage is induced.
The voltage will increase with rotor speed. It is possible to sense this voltage in one
of the three stator windings 88 because only two of the motor's windings are activated
at any one time, to determine the rotor 46 position, and to activate commutator
switches 104. The circuitry is much simpler and more reliable than Hall Effect
15 sensors which have been used in the past. Although a back emf control is the
presently preferred embodiment, a Hall effect driven commutation scheme could also
be used.
Back emf integrated circuit 106 provides sensors for detecting the back emf
from lines indicated at 107, and operates commutation switches 104 accordingly. A
20 presently preferred back emf integrated circuit includes a ML4411 motor controller
integrated circuit. Each commutation switch F.E.T. is preferably turned all the way
on or off for maximum power efficiency.
Back emf integrated circuit 106 also provides a start up mode operation when
the back emf is not present or large enough for detection. From zero to approximately
25 200 rpm's, motor 1 operates in stepper motor fashion as described hereinbefore.
Motor speed is controlled with a difference amplifier 108, which may take its speed
signal from either micro-controller 102 or speed adjust pot 110 as selected by
switch 112. A speed detection signal is available from the back emf integrated circuit
106 for this purpose.
30 Restart circuit 110 and micro-controller 102 monitor voltage developed across
sense resistor 111 (present preference is about 0.1 ohms) and the frequency signal
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from back emf integrated circuit 106 to determine whether motor 1 should be
restarted, i.e., due to a sudden increase or decrease in current or frequency. Switch
113 may be used to select between use of restart circuit 110, micro-controller 102, or
a manual restart switch 114. Controller 100 may be programmed to produce an alarm
5 signal if there are sudden changes in power consumption or frequency, as may occur
if heart strength weakens or improves. To protect the electronics from electromagnetic
interference (EMI), ferrite beads 116 are used with wires to an external power supply.
The electronics are preferably hermetically sealed in case 118, which is formed of a
high mu material to limit EMI.
10 Referring now to preferred bearing configuration embodiments, Fig. 6A
discloses a presently preferred ball-socket bearing configuration. The bearings are
comprised of bio-compatible material and, in the presently preferred embodiment, are
comprised of ceramic material. The ball-socket bearing 121 may be configured as
shown in Fig. 1, or may be otherwise configured. Ball 120 is preferably secured by
15 some securing means, such as glue or welding, along edge 128. Ball 120 could be
molded into one component, or split and secured as is known in the art. Ball 120 has
a spherical surface 122 that engages a mating seat spherical surface 124. A void or
bearing chamber 126 is filled with a bio-compatible material to prevent blood from
coming into this area and stagnating. In a preferred embodiment, bearing chamber
20 126 is left empty and allowed to fill with blood. The blood cross-links due to bearing
heat and takes on a soft, pliable, plastic texture. The cross-linked blood may perform,
to some extent, a bearing surface function. The cross-linked blood then prevents other
blood from entering the bearing and stagnating.
While the ball-socket bearing is the preferred configuration, another
25 configurations may be used. Shaft-journal bearing 130 provides shaft 132 secured to
component 134, which may be rotor 46, for rotation with a second component 136,
which may be diffuser 20. Journal sleeve 138 has a cylindrical bearing receiving
surface 140 for engaging the cylindrical shaft bearing surface 142. A bio-compatible
material in bearing chamber 144 is preferably cross-linked blood, as discussed
30 hereinbefore, which has leaked into this chamber, been heated, and solidified. Another
preferred embodiment of a shaft-journal bearing would include a shaft (not shown)
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extending through rotor 46 and engaging respective sleeves on flow straightener 18
and diffuser 20. As well, the flow straightener and/or diffuser, or relevant portions
thereof, may be made from a suitable material, such as zirconia, with the bearing
surfaces being formed or machined directly into that material. In a similar manner,
5 the bearing surfaces of bearing 121, 130, or other bearings could be machined into a
bearing mount component.
To avoid the problem of blood stagnation in the region of the bearing, several
bearing washing configurations, using directed blood flow or pump differential
pressures, may also be used as part of the present invention. Referring to Fig. 3, there
10 is shown a means for using a pump pressure differential for washing bearing 150
which includes shaft 152 and journal sleeve 153. High pressure region 154 produces
a blood flow through passage 156 to wash bearing 150 and exit to lower pressure
region 158. Thus, blood is prevented from stagnating behind bearing 150.
Another bearing embodiment (not shown) would include a pressure fed journal
15 bearing to form a hydrodynamic film that supports the shaft and loads so that the
bearing surfaces do not touch. Shaft 153 would be slightly undersize with respect to
a journal sleeve for this purpose. A pressure fed flow passage may be directed
through such a hydrodynamic journal bearing from a high pressure region 156 to a low
pressure region 158.
20 Fig. 6C illustrates another bearing washing method which includes a producing
bend 160 in pump housing i2. This bend places bearing 162 in a high velocity flow
area. Blood flow through bend 160 washes the bearing members, which include a
male portion 164 and mating member 166. Other configurations for this type
arrangement may be used, but the general principle is as described. The flow
25 straightener is removed in this embodiment, but may be included in another
embodiment where it does not necessarily need to act as a bearing support.
Fig. 6D and 6E illustrate yet another bearing arrangement embodiment. In this
embodiment, a bearing shaft 170 extends through journal sleeve 172. Bearing
shaft 170 has an oblong or substantially oval transverse cross-section, as shown in
30 Fig. 6E. This configuration produces flow paths 174 through journal sleeve 172 so
as to flush the bearing and prevent blood stagnation. Shaft 170 could also be fluted
-18-
MSC-22424-I
Express Mailing Certificate #FBI95855671US
Patent Application
so as to have spirals, slots, or other flow paths 174 formed along its periphery within
sleeve 172.
Fig. 6F shows a bearing configuration wherein rotor 46 is cantilevered with
respect to diffuser 20 using two bearings 180 and 182. Shaft 184 extends between the
5 two bearings. Each bearing includes a rotating ball surface, 186 and 188, mating with
a socket surface 190 and 192, respectively. Socket surfaces 190 and 192 are formed
in ceramic material sleeves 194 and 196, respectively. The bearings are "zero
tolerance" bearings. Thus, either the shaft 184 which runs through diffuser 20 or the
diffuser 20 itself must provide a takeup mechanism that keeps each ball surface 186
10 and 188 tightly engaged with a respective socket surfaces 190 and 192. For this
purpose, diffuser 20 could be made of compressible material. Alternatively,
diffuser 20 could receive injection molding around sleeves 194 or 196.
As another alternative, either a passive, active, or a combination passive-active
magnetic bearing suspension system (not shown) could be used to rotatably mount
15 rotor 46. For this embodiment, the rotor 46 would be axially positioned and/or
bearing surfaces would be suspended with respect to each other using magnetic force.
The method of the present invention is illustrated in Fig. 8 which shows a test
matrix for optimizing the pump parameters which are believed to affect hemolysis.
This method enables optimization of pump parameters as discussed hereinafter with
20 a minimum number of tests. Although this matrix is designed for a blood pump with
no inducer or flow straightener, it is believed that the method of the present invention
is clearly illustrated with this example, and may be used to improve most other blood
pump designs with respect to hemolysis, thrombus, pump efficiency, cost, and other
important factors. Using this approach, it is possible to thoroughly investigate many
25 parameters in an organized, methodical approach to achieve highly desired goals, such
as optimum pump performance and minimum hemolysis.
To apply this method, it was first necessary to identify the pump parameters
that were believed to affect hemolysis. The variables are listed at the headings of the
test matrix, and include blade tip shape, radial clearance, axial clearance, number of
30 blades, and impeller length. To judge effectively the impact of each variable on
hemolysis, the method of the present invention requires that all pump dimensions be
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held constant while only one variable is changed. As shown in the matrix of Fig. 8,
16 different tests are used. Preferably, each test is made at least three different times
to provide statistical results and check consistency.
The information learned in initial tests is used later in the matrix. For
5 example, tests 1 and 2 compare the effects of flat and round blade tip geometries. The
least hemolytic of the two is then used in all remaining tests. If there is no
statistically significant difference, then the result that provides superior hydrodynamic
performance is used. If there is no hydrodynamic difference, then the least expensive
parameter to manufacture is used. Test conditions are constant for each parameter.
10 All tests were made using bovine blood at a flow of 5 liters/min against 100 mm Hg.
The duration of each test was 20 minutes. The pump circulates blood through a test
loop having a 500 cc blood reservoir which was conveniently a 500 cc blood bag.
The 500 cc blood bag is preferably changed after each version of each parameter is
tested.
15 In order to compare various impeller and stator blade geometries within a
reasonable time period, a stereolithography technique was used to quickly realize the
complex shapes. This technique relies on a laser beam that scans the surface of a
liquid acrylic polymer. The polymer hardens under the influence of the laser, and
layer by layer a solid shaped is formed from the liquid surface.
20 To compare hemolysis results, an index of hemolysis (IH) is used. This is
defined as the amount of hemoglobin liberated in grams per 100 liters of blood
pumped against 100 mm Hg. In equation form:
IH = AHb x V x ( I-Hi) X
100 (i)
( Flow x Time) '
where:
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IH equals amount of hemoglobin liberated in grams per 100 liters of blood
pumped against 100 mm Hg;
Ht is the hematocrit in decimal percent;
V is the blood volume in liters;
zM-Ib is the amount of hemoglobin liberated in a fixed time period in
grams/liter;
Flow is the flow rate in liters per minute; and
Time is the total time in minutes at that flow rate.
The final results are seen in the matrix of Fig. 8. Other more detailed factors
10 of testing in accord with the method of this invention are discussed more thoroughly
in the articles which have been named previously and incorporated herein by
reference.
As to manufacturing and usage considerations, pump 10 is preferably
manufactured using materials designed to be buoyant inside the body to make the
15 completed pump neutrally buoyant or approximately neutrally buoyant. This
minimizes stress on stitches or other means used to position the pump within the body.
Thus, the rotor, rotor blades, and/or other components may be made with a lightweight
material having sufficient thickness to produce a buoyant effect.
20
25
Pump 10 has numerous uses as a blood pump, including use as a portable
blood pumping unit for field service. Pump 10 may also be used for other clinical
applications involving other fluids. It could, for instance, be used in a compact heart-
lung machine. Due to the small volume and size of pump 10, it can be placed close
to a patient to minimize shock caused when initiating blood pump operation using a
saline solution. Larger pumps, with larger volume, may be awkward to move close
by a patient to eliminate this shock.
Thus, the blood pump of the present invention, particularly when optimized
using the method of the present invention, has many advantages over the prior art.
For instance, there are no blood seals which require bearing purge systems. No Hall
Effect sensors are required which may tend to limit motor control reliability due to
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their complexity. As well, pump 10 provides low power consumption and very low
levels of hemolysis.
The foregoing disclosure and description of the invention is illustrative and
explanatory thereof. It will be appreciated by those skilled in the art that various
changes in the size, shape, materials, as well as in the details of the illustrated
construction, may be made without departing from the spirit of the invention.
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ABSTRACT OF THE INVENTION
A rotary blood pump includes a pump housing for receiving a flow
straightener, a rotor mounted on rotor bearings and having an inducer portion and an
impeller portion, and a diffuser. The entrance angle, outlet angle, axial and radial
5 clearances of blades associated with the flow straightener, inducer portion, impeller
portion and diffuser are optimized to minimize hemolysis while maintaining pump
efficiency. The rotor bearing includes a bearing chamber that is filled with cross-
linked blood or other bio-compatible material. A back emf integrated circuit regulates
rotor operation and a microcomputer may be used to control one or more back emf
10 integrated circuits. A plurality of magnets are disposed in each of a plurality of
impeller blades with a small air gap. A stator may be axially adjusted on the pump
housing to absorb bearing load and maximize pump efficiency.
0/
c.O
0
O0
('xl
O0
oO
c.D
t
/
0
0
x_
Ii
0
o0
CO
o0
o0
O0
CD
0
C",,I
6
CD
IJ_
u_
b_
_0
b_
\
uO
00
0
0
_3
C_
LL
4
C_
LL
+C_
0
+
0
+
0
O0
V
0
CO
+
coo +
0000 0
OE
i, 0
co
0
0
L_O
0
LL
cO
o_-_
00
O_
cO
CO
_--C'_
,_-.o0 C_
• "--,__0
_C3
0
0/
l'-
Ill """'_..
_0__ ,'_,-,.,,,i
___ -,.-,.. t
ii t _I I
t
II ¢_ t
c._
LL_
0
r"..
c'.,!
Ld
CO
0
i,i
.'..' ill I
0I
O0
0
o_
I
0 0
o_00
0
o_
0 o
_0OZZ
0
Oo
0
0(5
o
0
0
00000
__ 0
0
o_
O0
o_ _0 Z Z
0
t_D
0
0
O
LO
0
0
I
LOO
O0
dd
Z
0
0
0
I
o o
O0
O0
0
OZ 0 ZZ (0 tt') ZZ
W")
0
(5
I
LO _O
O0
O0
od
0
I
0 0
O0
c_o
zz _)e4 zz
0
0
c;
O o
O o
i.O o4
I I
OO _4D OO
_"O I 04O
NO4 _O1'O ',-- ',-
O
OZ C_ ZZ _04 ZZ
w
Z .
v__
_WwWo
__--
0
w
-t-
O
z_
ffl
w
Z
"w-
0
"1-
i,I
Z°_
!,,,,.,(Ab-WW
.J
wZ
_-wW
Z
Z _
wW
<
w
-r w
0 n-
Z (D
_. w
F--
hi
W W W
0 0 0
Z Z Z
W W W w W W
tw O t_ r_ tY _D
WZ wZ W Z
"#_ "
W _ Lt)tY
r,"0-B ° "' "w hlO" W
ww w L_ wW W
WW O bJW vW W
m rY
Z
IL_ _0 CO CO G3 (0 f43 r.O tuD CO (O _,0 cO (O Q3 t._IDX _ ooooooo6oooaoooo
rr
<
U3
UJ
n
Ct.
0
...J
LL
._J
<
_w_" n
UJ
r7 W
w 0
0 W'
_ _ e_ cq m b- 0
0 _ OOOOOO7z ddddodW
:LU
0 tO
0 0 0 0
6 _5 o c_
W0
0 0 0 0 0 Z =
W
0 0 0 0
= 0 0 0 0
6_0 0 0
e.
<
o.........
m _- 09
d
l/1 i_
>
.'It:
I-
c0.
U_I
T
E
E
0
o
,,,,,-
e-
"0
"_ ,--- o
0 0
_ _g.__
o >
i-_-_ _ o
o -g =_
_J o
1.13
I-
Z _
__o
w ff
_ O
-__
0_ u-
I.U W
m _DD ZZ
DDDDD
00000
www
Z<_OOw
30
I
0 0 0
_0 0xl ,-
LL O0
O_Ld
LdC) W
_j_rY
• U')
S
_.o
0 Z
c; z
0
o4 H-
0 U')
0
,-- cl
6_
o.._
00._
C_
C_
LL
0
oq
0
